相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ten-Year Retention Rate of Infliximab in Patients with Behcet's Disease-Related Uveitis
Claudia Fabiani et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2019)
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis
Claudia Fabiani et al.
CLINICAL RHEUMATOLOGY (2019)
Randomized Controlled Study to Evaluate the Efficacy of Adalimumab in Patients with Different Forms of Refractory Uveitis
Friederike Mackensen et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2018)
Predictors of sustained clinical response in patients with Beh double dagger et's disease-related uveitis treated with infliximab and adalimumab
Claudia Fabiani et al.
CLINICAL RHEUMATOLOGY (2018)
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies
Claudia Fabiani et al.
CLINICAL RHEUMATOLOGY (2018)
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis Fundamentals Of Care for UveitiS (FOCUS) Initiative
Andrew D. Dick et al.
OPHTHALMOLOGY (2018)
Adalimumab effectiveness in Beh‡et's disease: short and long-term data from a multicenter retrospective observational study
Antonio Vitale et al.
CLINICAL RHEUMATOLOGY (2017)
Efficacy and safety of adalimumab in Beh‡et's disease-related uveitis: a multicenter retrospective observational study
Claudia Fabiani et al.
CLINICAL RHEUMATOLOGY (2017)
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial
Quan Dong Nguyen et al.
LANCET (2016)
Adalimumab in Patients with Active Noninfectious Uveitis
Glenn J. Jaffe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis A Multicenter Study From the French Uveitis Network
Helene Vallet et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Efficacy of anti-TNF alpha in severe and/or refractory Behcet's disease: Multicenter study of 124 patients
H. Vallet et al.
JOURNAL OF AUTOIMMUNITY (2015)
Expert Panel Recommendations for the Use of Anti-Tumor Necrosis Factor Biologic Agents in Patients with Ocular Inflammatory Disorders
Grace Levy-Clarke et al.
OPHTHALMOLOGY (2014)
Incidence of Visual Improvement in Uveitis Cases with Visual Impairment Caused by Macular Edema
Marc H. Levin et al.
OPHTHALMOLOGY (2014)
Degree, duration, and causes of visual impairment in eyes affected with ocular tuberculosis
Soumyava Basu et al.
JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION (2014)
Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients
Manuel Diaz-Llopis et al.
OPHTHALMOLOGY (2012)
Clinical Review: Update on Treatment of Inflammatory Macular Edema
Annette Ossewaarde-van Norel et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2011)
One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behcet's disease refractory to standard immunosuppressive drugs
AnnaRita Giardina et al.
RHEUMATOLOGY INTERNATIONAL (2011)
New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS)
J. Sieper et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Safety and efficacy of infliximab therapy in active Behcet's uveitis: an open-label trial
H. Al-Rayes et al.
RHEUMATOLOGY INTERNATIONAL (2008)
Cross-cultural adaptation of the Behcet's disease current activity form (BDCAF) to Brazilian Portuguese language
F. S. Neves et al.
CLINICAL RHEUMATOLOGY (2007)
Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop
DA Jabs et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)
Medical treatment of cystoid macular edema
A Rothova
OCULAR IMMUNOLOGY AND INFLAMMATION (2002)
分享论文
